documents: FDA-2020-E-2333-0006

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-E-2333-0006 FDA FDA-2020-E-2333 Determination of Regulatory Review Period for Purposes of Patent Extension; ROZLYTREK INJECTION; Correction Notice Correction 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z   2023-11-17T21:08:13Z 2023-25489 0 0 090000648628cc11

Links from other tables